Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.022 | 0.7 |